Plant Medicine Takes Center Stage In Pharma's Shadow: Cannabis And The Rise of Natural Remedies

In recent years, the healthcare landscape has witnessed a profound shift as plant-based medicines, including cannabis, have emerged as contenders to traditional pharmaceuticals.

Plant medicine refers to the use of natural substances derived from plants and herbs for therapeutic and medicinal purposes, often encompassing traditional and holistic healing practices.

These natural remedies, derived from various plants and herbs, are increasingly gaining market share in the wellness and healthcare industry. In the changed post-COVID-19 business landscape, the global market for herbal medicines, estimated at $135.8 billion in 2022, is projected to reach $248.6 billion by 2030, growing at a CAGR of 7.9%.

Plant-Based Medicines And The Cannabis Industry

As the plant medicine industry continues to grow, it is crucial for investors, entrepreneurs and healthcare professionals to stay informed about this transformative sector. That's where the Benzinga Cannabis Capital Conference comes in.

Join us at the world's largest gathering of cannabis investors, in Chicago from September 27 to 28.

Our expert panel, featuring industry leaders like Michael Astone, CEO, of Arcstone, Bill Panagiotakopoulos, CEO, of Safe Supply, David Craig, CEO of Harbour Solution, and Geoff Benic, former CEO of Aleafia, will analyze the growth of plant medicine and its interconnectedness with the cannabis sector.

Gain valuable insights into the future of healthcare and investment opportunities in this exciting field.

Why Plant-Based Medicines Are Gaining Ground

Growing Consumer Demand: A significant driver of the plant medicine surge is the increasing consumer demand for holistic and natural remedies. People are actively seeking alternatives to conventional pharmaceuticals, and this shift in consumer preference is reflected in the rising sales of plant-based products. The World Health Organization stated that trade in medicinal plants, herbal raw materials and herbal drugs is growing at an annual rate of about 15%.

Fewer Side Effects: Plant-based medicines often come with fewer side effects compared to their synthetic counterparts. Patients are growing increasingly wary of the long list of potential side effects that accompany many pharmaceutical drugs.

Research: Many plant-based medicines have a long history of traditional use, which has sparked renewed interest in their therapeutic properties. Furthermore, advancements in scientific research are shedding light on the specific compounds within plants that deliver health benefits.

Cost-Effective Solutions: The ongoing healthcare crisis and the burden of expensive pharmaceuticals have led many individuals to explore plant-based medicines as a more budget-friendly alternative.

Furthermore, innovative companies like Harbour Solution are delving into previously overlooked plants like the coca leaf. Recognized for its vast array of health and medicinal benefits, the coca leaf, when processed correctly, can deliver remedies without the notorious cocaine content, aligning with the rising demand for natural and holistic treatments.

Don't miss out on this unique opportunity to learn more about investing in the plant medicine revolution. Register for the Benzinga Cannabis Capital Conference today and be part of the conversation shaping the future of healthcare and wellness. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechCannabisNewsPsychedelicsEmerging MarketsHealth CareCommoditiesRetail SalesMarketsGeneralAleafiaArcstoneBill PanagiotakopoulosCCCDavid CraigGeoff BenicHarbour SolutionMichael Astoneplant medicineSafe Supply
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...